Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders : Quasi-Experimental Study Using Interrupted Time Series
©Iyn-Hyang Lee, So Young Kim, Susin Park, Jae Gon Ryu, Nam Kyung Je. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 21.02.2024..
BACKGROUND: Opioids have traditionally been used to manage acute or terminal pain. However, their prolonged use has the potential for abuse, misuse, and addiction. South Korea introduced a new health care IT system named the Narcotics Information Management System (NIMS) with the objective of managing all aspects of opioid use, including manufacturing, distribution, sales, disposal, etc.
OBJECTIVE: This study aimed to assess the impact of NIMS on opioid use.
METHODS: We conducted an analysis using national claims data from 45,582 patients diagnosed with musculoskeletal and connective tissue disorders between 2016 and 2020. Our approach included using an interrupted time-series analysis and constructing segmented regression models. Within these models, we considered the primary intervention to be the implementation of NIMS, while we treated the COVID-19 outbreak as the secondary event. To comprehensively assess inappropriate opioid use, we examined 4 key indicators, as established in previous studies: (1) the proportion of patients on high-dose opioid treatment, (2) the proportion of patients receiving opioid prescriptions from multiple providers, (3) the overlap rate of opioid prescriptions per patient, and (4) the naloxone use rate among opioid users.
RESULTS: During the study period, there was a general trend of increasing opioid use. After the implementation of NIMS, significant increases were observed in the trend of the proportion of patients on high-dose opioid treatment (coefficient=0.0271; P=.01) and in the level of the proportion of patients receiving opioid prescriptions from multiple providers (coefficient=0.6252; P=.004). An abrupt decline was seen in the level of the naloxone use rate among opioid users (coefficient=-0.2968; P=.04). While these changes were statistically significant, their clinical significance appears to be minor. No significant changes were observed after both the implementation of NIMS and the COVID-19 outbreak.
CONCLUSIONS: This study suggests that, in its current form, the NIMS may not have brought significant improvements to the identified indicators of opioid overuse and misuse. Additionally, the COVID-19 outbreak exhibited no significant influence on opioid use patterns. The absence of real-time monitoring feature within the NIMS could be a key contributing factor. Further exploration and enhancements are needed to maximize the NIMS' impact on curbing inappropriate opioid use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
JMIR public health and surveillance - 10(2024) vom: 21. Feb., Seite e47130 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lee, Iyn-Hyang [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 22.02.2024 Date Revised 09.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2196/47130 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368715035 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368715035 | ||
| 003 | DE-627 | ||
| 005 | 20240309232318.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240222s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2196/47130 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1321.xml |
| 035 | |a (DE-627)NLM368715035 | ||
| 035 | |a (NLM)38381481 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lee, Iyn-Hyang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders |b Quasi-Experimental Study Using Interrupted Time Series |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.02.2024 | ||
| 500 | |a Date Revised 09.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a ©Iyn-Hyang Lee, So Young Kim, Susin Park, Jae Gon Ryu, Nam Kyung Je. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 21.02.2024. | ||
| 520 | |a BACKGROUND: Opioids have traditionally been used to manage acute or terminal pain. However, their prolonged use has the potential for abuse, misuse, and addiction. South Korea introduced a new health care IT system named the Narcotics Information Management System (NIMS) with the objective of managing all aspects of opioid use, including manufacturing, distribution, sales, disposal, etc | ||
| 520 | |a OBJECTIVE: This study aimed to assess the impact of NIMS on opioid use | ||
| 520 | |a METHODS: We conducted an analysis using national claims data from 45,582 patients diagnosed with musculoskeletal and connective tissue disorders between 2016 and 2020. Our approach included using an interrupted time-series analysis and constructing segmented regression models. Within these models, we considered the primary intervention to be the implementation of NIMS, while we treated the COVID-19 outbreak as the secondary event. To comprehensively assess inappropriate opioid use, we examined 4 key indicators, as established in previous studies: (1) the proportion of patients on high-dose opioid treatment, (2) the proportion of patients receiving opioid prescriptions from multiple providers, (3) the overlap rate of opioid prescriptions per patient, and (4) the naloxone use rate among opioid users | ||
| 520 | |a RESULTS: During the study period, there was a general trend of increasing opioid use. After the implementation of NIMS, significant increases were observed in the trend of the proportion of patients on high-dose opioid treatment (coefficient=0.0271; P=.01) and in the level of the proportion of patients receiving opioid prescriptions from multiple providers (coefficient=0.6252; P=.004). An abrupt decline was seen in the level of the naloxone use rate among opioid users (coefficient=-0.2968; P=.04). While these changes were statistically significant, their clinical significance appears to be minor. No significant changes were observed after both the implementation of NIMS and the COVID-19 outbreak | ||
| 520 | |a CONCLUSIONS: This study suggests that, in its current form, the NIMS may not have brought significant improvements to the identified indicators of opioid overuse and misuse. Additionally, the COVID-19 outbreak exhibited no significant influence on opioid use patterns. The absence of real-time monitoring feature within the NIMS could be a key contributing factor. Further exploration and enhancements are needed to maximize the NIMS' impact on curbing inappropriate opioid use | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a NIMS | |
| 650 | 4 | |a Narcotics Information Management System | |
| 650 | 4 | |a addiction | |
| 650 | 4 | |a chronic noncancer pain | |
| 650 | 4 | |a monitoring | |
| 650 | 4 | |a mortality rate | |
| 650 | 4 | |a narcotics | |
| 650 | 4 | |a opioid | |
| 650 | 4 | |a opioid misuse | |
| 650 | 4 | |a opioid prescription | |
| 650 | 4 | |a overdose | |
| 650 | 4 | |a prevention | |
| 650 | 4 | |a terminal pain | |
| 650 | 4 | |a time series | |
| 650 | 4 | |a web-based system | |
| 650 | 7 | |a Narcotics |2 NLM | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 650 | 7 | |a Naloxone |2 NLM | |
| 650 | 7 | |a 36B82AMQ7N |2 NLM | |
| 700 | 1 | |a Kim, So Young |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Susin |e verfasserin |4 aut | |
| 700 | 1 | |a Ryu, Jae Gon |e verfasserin |4 aut | |
| 700 | 1 | |a Je, Nam Kyung |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JMIR public health and surveillance |d 2015 |g 10(2024) vom: 21. Feb., Seite e47130 |w (DE-627)NLM257939679 |x 2369-2960 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2024 |g day:21 |g month:02 |g pages:e47130 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2196/47130 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2024 |b 21 |c 02 |h e47130 | ||